Both at baseline and at follow-up, all PD patients fulfilled the clinical diagnostic criteria for PD54 and were defined as having sPD by the absence of known PD-causing familial mutations (PARK1–18) and a negative family history of PD16. This evidence concerns the gene SNCA and Parkinson disease.